Wolfgang Miesbach: 43-Year Study Links Black Coffee to Reduced Dementia Risk
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about a recent article by Yu Zhang et al, published in JAMA:
“Black coffee, lower dementia risk ?
What a 43-year JAMA demonstrates: In a prospective study of 131,821 health professionals followed for up to 43 years, moderate intake of black caffeinated coffee (about 2–3 cups/day) and tea (1–2 cups/day) was associated with lower dementia risk and slightly better cognitive performance, whereas decaf and coffee with milk did not show the same benefit.
The authors used repeated dietary questionnaires and time-updated models to capture long-term habits and adjust for lifestyle, vascular risk factors, and overall diet quality, strengthening the robustness of the associations.
Possible explanations include caffeine’s effects on amyloid and tau pathways and adenosine signaling, polyphenols and other bioactive compounds that dampen oxidative stress and neuroinflammation, and favorable impacts on insulin sensitivity and vascular function—all of which may help preserve brain health over decades. ”
Title: Coffee and Tea Intake, Dementia Risk, and Cognitive Function
Authors: Yu Zhang, Yuxi Liu, Yanping Li, Yuhan Li, Xiao Gu, Jae H. Kang, A. Heather Eliassen, Molin Wang, Eric B. Rimm, Walter C. Willett, Frank B. Hu, Meir J. Stampfer, Dong D. Wang
Read the Full Article on JAMA
Find more posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Sep 10, 2026, 15:51Christopher Bocquet: A Call for Feedback on the Proposed 13th Edition of Standards for Biotherapy Services
-
Sep 10, 2026, 15:45Amos Gitonga Mbaabu: GASCDO Conference in Nairobi – Translating Sickle Cell Innovations into Equitable Care
-
Sep 10, 2026, 15:36Majdouline El Moussaoui: What If AA Amyloidosis is the First Clue to an Undiagnosed Monogenic Autoinflammatory Disease?
-
Sep 10, 2026, 15:21Pathogenesis and Emerging Targeted Therapies in Myeloproliferative Neoplasms – NEJM Group
-
Sep 10, 2026, 15:06YSMU Remembers Honorary Doctor and Nobel Laureate Prof. Ada Yonath
-
Sep 10, 2026, 14:39Piotr Czempik: ROTEM Guided Anticoagulation in Severe Thrombocytopenia and Acute VTE
-
Sep 10, 2026, 14:30Adil Aftab: Acute VTE Treatment and Anticoagulation Considerations in Renal Dysfunction
-
Sep 10, 2026, 14:21Seth Green: Testosterone Replacement Therapy and VTE Risk When Is the Risk Highest
-
Sep 10, 2026, 13:56Sumyea Kabir: Wet Hijama and Blood Donation Why Deferral Matters